Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Antiphospholipid Syndrome
|
17 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Childhood Leukemia
|
140 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Coronary Arteriosclerosis
|
440 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Eosinophilia
|
23 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||
Eosinophilic disorder
|
22 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||
leukemia
|
144 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Malignant neoplasm of breast
|
3417 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Malignant neoplasm of colon and/or rectum
|
502 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Malignant neoplasm of endometrium
|
197 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Multiple Sclerosis
|
1022 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||
Myeloid Leukemia, Chronic
|
115 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Myocardial Infarction
|
680 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Primary malignant neoplasm of lung
|
981 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Primary Myelofibrosis
|
29 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Thrombocythemia, Essential
|
37 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Autoimmune hepatitis
|
22 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.020 | 1.000 | 2 | 2014 | 2017 | |||||
Diabetes
|
710 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.020 | 0.500 | 2 | 2016 | 2017 | |||||
Diabetes Mellitus
|
824 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.020 | 0.500 | 2 | 2016 | 2017 | |||||
Malignant neoplasm of lung
|
1142 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.020 | 1.000 | 2 | 2015 | 2019 | |||||
Diastolic blood pressure
|
1037 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.700 | 1.000 | 10 | 2009 | 2019 | |||||
Systolic Pressure
|
1931 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.700 | 1.000 | 5 | 2009 | 2018 | |||||
Adenocarcinoma of large intestine
|
432 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.700 | 1.000 | 4 | 2015 | 2019 | |||||
COLORECTAL CANCER, SUSCEPTIBILITY TO, 1
|
374 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.700 | 1.000 | 4 | 2015 | 2019 | |||||
COLORECTAL CANCER, SUSCEPTIBILITY TO, 10
|
370 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.700 | 1.000 | 4 | 2015 | 2019 | |||||
COLORECTAL CANCER, SUSCEPTIBILITY TO, 12
|
373 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.700 | 1.000 | 4 | 2015 | 2019 |